Drug firm Concordia overcharged NHS with 6,000% price rise

Competition watchdog accuses Canadian firm of abusing dominant position on thyroid drug with price per pack jumping from £4.46 to £258 in 10 years

Canadian drug company Concordia has overcharged the NHS millions of pounds for a lifechanging thyroid drug, according to Britain’s competition watchdog.

The Competition and Markets Authority said it had provisionally found that Concordia had “abused its dominant position to overcharge the NHS” by hiking the price of liothyronine by 6,000% in 10 years.

Related: Drug giants threaten NHS with legal action over cheaper drug that could save £84m a year

Continue reading... November 21, 2017 at 02:14PM